Nichi BRITE Beta glucan als voedingssupplement bij alvleesklierkanker; bemoedigende klinische resultaten gemeld door het Chikamori ziekenhuis, Japan.

The Nichi BRITE Beta 1,3-1,6 Glucan is produced as an exo-polysaccharide by Aureobasidium Pullulans in a GMP certified facility in Japan and is water soluble. The subjects of Nichi BRITE group in the study were given 250mg Beta glucan as an active ingredient per day for 22 days as an adjuvant, while control group had a placebo instead; both groups were given standard of care treatment. The quantity consumed during the study by each patient is equivalent to four boxes of Nichi BRITE, which comes in a box of 24 sachets, 1.5-gram granule as content with 63 mg active beta glucan as ingredient per sachet. Oral administration was undertaken when possible, and when it was not possible, administration was through feeding gastrostomy or nasogastric tube. No adverse reactions were observed. The efficacy in terms of immune enhancement, cancer biomarker reduction and longer mean survival were reported with Nichi Brite as an adjuvant. (Graphic: Business Wire)

  • The Nichi BRITE Beta 1,3-1,6 Glucan is produced as an exo-polysaccharide by Aureobasidium Pullulans in a GMP certified facility in Japan and is water soluble. The subjects of Nichi BRITE group in the study were given 250mg Beta glucan as an active ingredient per day for 22 days as an adjuvant, while control group had a placebo instead; both groups were given standard of care treatment. The quantity consumed during the study by each patient is equivalent to four boxes of Nichi BRITE, which comes in a box of 24 sachets, 1.5-gram granule as content with 63 mg active beta glucan as ingredient per sachet. Oral administration was undertaken when possible, and when it was not possible, administration was through feeding gastrostomy or nasogastric tube. No adverse reactions were observed. The efficacy in terms of immune enhancement, cancer biomarker reduction and longer mean survival were reported with Nichi Brite as an adjuvant. (Graphic: Business Wire)

TOKIO--()--Nichi BRITE Beta glucan-toediening resulteerde in een verbetering van immuniteit, gevolgd door een vermindering van biomarkers van alvleesklierkanker en die van het recidief, bij patiënten die een chirurgische resectie van een kwaadaardige alvleesklierkankertumor ondergingen. De presentatie werd gegeven op de ASCO® Breakthrough-bijeenkomst in Yokohama, Japan. IgA en CD209, markers van immuniteit verbeterden, terwijl CA19-9, de marker van alvleesklierkanker en CD44, die van belang is bij het terugkomen en de ernst van kanker, significant afnamen bij patiënten die Nichi BRITE kregen, vergeleken met de controlegroep in het onderzoek door gastro-enterologische chirurgen en het voedingsondersteunende team van het Chikamori ziekenhuis, Kochi, Japan.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is.

Contacts

Samuel JK Abraham
info@gncorporation.com

Contacts

Samuel JK Abraham
info@gncorporation.com